3,000 bipolar patients monitored for olanzapine use and weight gain prevention
NCT ID NCT07263191
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study watches 3,000 people with bipolar disorder who are taking olanzapine. Researchers want to see how the drug is used and if teaching patients about weight gain can help prevent it. No new treatment is given; it only collects information from regular care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHA Bundang Medical Center
RECRUITINGSeongnam, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a web app get people moving in mental health residential care?
- Smartwatch data may forecast bipolar mood swings
- Could a talking therapy ease the weight of bipolar depression?
- Could a common antibiotic and supplement lift bipolar depression?
- Brain markers may reveal who responds best to suicide treatments
- Can a tailored self-management program improve health outcomes for those with serious mental illness?